| scholarly article | Q13442814 |
| P50 | author | David B. Weiner | Q67465894 |
| P2093 | author name string | Jian Yan | |
| Panyupa Pankhong | |||
| Matthew P Morrow | |||
| Dominick J Laddy | |||
| Kimberly A Schoenly | |||
| Neil Cisper | |||
| P2860 | cites work | A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques | Q43602552 |
| Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. | Q44794043 | ||
| IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge | Q45750840 | ||
| Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance | Q48019883 | ||
| Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques. | Q51977322 | ||
| IL-28A is a key regulator of T-cell-mediated liver injury via the T-box transcription factor T-bet. | Q54561043 | ||
| SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques | Q57081543 | ||
| Coadministration of IL-12 or IL-10 expression cassettes drives immune responses toward a Th1 phenotype | Q77124662 | ||
| Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques | Q80204825 | ||
| IL-28, IL-29 and their class II cytokine receptor IL-28R | Q24323830 | ||
| IL-28 and IL-29: newcomers to the interferon family | Q28293519 | ||
| Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells | Q28297426 | ||
| DNA vaccines for HIV: challenges and opportunities. | Q30357322 | ||
| Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens | Q33346277 | ||
| Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge | Q35884740 | ||
| IFN-lambda: novel antiviral cytokines | Q36492388 | ||
| Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business". | Q36498186 | ||
| Chemical adjuvants for plasmid DNA vaccines. | Q36756851 | ||
| Cytokines as adjuvants for improving anti-HIV responses | Q37057084 | ||
| The Foxp3+ regulatory T cell: a jack of all trades, master of regulation | Q37088900 | ||
| IL-12R beta 2 promotes the development of CD4+CD25+ regulatory T cells | Q37184595 | ||
| Induction of immunoglobulin synthesis by CD4+ T cell clones | Q40621396 | ||
| Targeting of human dendritic cells by autologous NK cells. | Q40914002 | ||
| In vitro effects of IL-12 on HIV-1-specific CTL lines from HIV-1-infected children. | Q41029721 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| P304 | page(s) | 5868-77 | |
| P577 | publication date | 2009-06-04 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity | |
| P478 | volume | 113 |
| Q35196530 | A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge. |
| Q34033407 | Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity |
| Q24611884 | Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection |
| Q30375785 | An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates. |
| Q40551804 | Antibodies to HBV surface antigen in relation to interferon-λ3 in hemodialysis patients |
| Q36425910 | Antitumor activity of type I and type III interferons in BNL hepatoma model |
| Q34853230 | Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infection. |
| Q34604379 | Associations of IFN-γ rs2430561 T/A, IL28B rs12979860 C/T and ERα rs2077647 T/C polymorphisms with outcomes of hepatitis B virus infection: a meta-analysis |
| Q48172873 | CD8+ T Cells Lack Local Signals To Produce IFN-γ in the Skin during Leishmania Infection. |
| Q36258203 | Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge |
| Q42246885 | Chronic hepatitis B and IL28B rs12979860 polymorphism: preliminary study |
| Q47148111 | Circulating Interferon-λ3, Responsiveness to HBV Vaccination, and HBV/HCV Infections in Haemodialysis Patients. |
| Q37546867 | Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort |
| Q36694820 | Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA |
| Q89216134 | Correlations of indoleamine 2,3-dioxygenase, interferon-λ3, and anti-HBs antibodies in hemodialysis patients |
| Q37309264 | Cyclophilin A as a potential genetic adjuvant to improve HIV-1 Gag DNA vaccine immunogenicity by eliciting broad and long-term Gag-specific cellular immunity in mice |
| Q38266253 | Cytokines and HCV-related autoimmune disorders |
| Q35960209 | Cytokines and HCV-related disorders |
| Q34750577 | Dendritic cells in hepatitis C virus infection: key players in the IFNL3-genotype response. |
| Q36694881 | Electrogenetherapy of B16.F10 murine melanoma tumors with an interleukin-28 expressing DNA plasmid |
| Q34240279 | Elevated levels of serum IL-12 and IL-18 are associated with lower frequencies of CD4(+)CD25 (high)FOXP3 (+) regulatory t cells in young patients with type 1 diabetes |
| Q42232714 | Exploration of genetically determined resistance against hepatitis C infection in high-risk injecting drug users. |
| Q35815577 | Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites. |
| Q54793615 | Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir. |
| Q34147621 | Genetic variations in IL28B and allergic disease in children |
| Q35108680 | HIV-1 adenoviral vector vaccines expressing multi-trimeric BAFF and 4-1BBL enhance T cell mediated anti-viral immunity |
| Q30226803 | Hantavirus protein interactions regulate cellular functions and signaling responses. |
| Q37862746 | Host genetics in immune-mediated hepatitis C virus clearance |
| Q37867104 | IFN-α as a vaccine adjuvant: recent insights into the mechanisms and perspectives for its clinical use. |
| Q37997043 | IFN-λ and IgE-mediated allergic disease: a potential future role? |
| Q34147632 | IFN-λ exerts opposing effects on T cell responses depending on the chronicity of the virus infection |
| Q47095129 | IFN-λ1 in CHO cells: its expression and biological activity |
| Q33586624 | IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection |
| Q33525565 | IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE) |
| Q36947326 | IL-28B down-regulates regulatory T cells but does not improve the protective immunity following tuberculosis subunit vaccine immunization |
| Q24630281 | IL-28B/IFN-lambda 3 drives granzyme B loading and significantly increases CTL killing activity in macaques |
| Q36694816 | IL-4 and IFN-γ induced by human immunodeficiency virus vaccine in a schistosome infection model |
| Q43047523 | IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes |
| Q37800518 | IL28B and the Control of Hepatitis C Virus Infection |
| Q37972766 | IL28B genetic polymorphism testing in the era of direct acting antivirals therapy for chronic hepatitis C: ten years too late? |
| Q42985791 | IL28B genetic variation and hepatitis C virus-specific CD4(+) T-cell responses in anti-HCV-positive blood donors |
| Q35042843 | IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection |
| Q34612816 | IL28B polymorphism correlates with active hepatitis in patients with HBeAg-negative chronic hepatitis B. |
| Q34279852 | IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection |
| Q28740359 | Immune modulation through 4-1BB enhances SIV vaccine protection in non-human primates against SIVmac251 challenge |
| Q37480261 | Immunogenicity evaluation of a DNA vaccine expressing the hepatitis C virus non-structural protein 2 gene in C57BL/6 mice |
| Q34003764 | Induction and evasion of innate antiviral responses by hepatitis C virus |
| Q36184362 | Induction of robust cellular immunity against HPV6 and HPV11 in mice by DNA vaccine encoding for E6/E7 antigen. |
| Q30401513 | Influenza 2009 pandemic: Cellular immunemediated surveillance modulated by TH17 & Tregs. |
| Q47143961 | Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs. |
| Q21296797 | Interferon lambda: a new sword in cancer immunotherapy |
| Q92461586 | Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin |
| Q92761688 | Interferon-λ orchestrates innate and adaptive mucosal immune responses |
| Q26801049 | Interferon-λ: Immune Functions at Barrier Surfaces and Beyond |
| Q38064651 | Interferon-λs: special immunomodulatory agents and potential therapeutic targets. |
| Q37788270 | Interferons as potential adjuvants in prophylactic vaccines |
| Q54233764 | Interleukin gene polymorphisms and susceptibility to HIV-1 infection: a meta-analysis |
| Q43445309 | Interleukin-28B polymorphism in hepatitis C and liver transplantation |
| Q38844555 | Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigs. |
| Q38974225 | Lambda Interferons: New Cytokines with Old Functions |
| Q91670701 | Macrophage Coordination of the Interferon Lambda Immune Response |
| Q35232840 | Modulation of SIV and HIV DNA vaccine immunity by Fas-FasL signaling |
| Q28236770 | Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination |
| Q37684017 | Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection. |
| Q34725547 | Regulatory T cells in HIV immunotherapy |
| Q35208006 | Role of IFN-ks, IFN-ks related genes and the DEPDC5 gene in Hepatitis B virus-related liver disease |
| Q37070349 | Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery |
| Q28740321 | Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults |
| Q37845927 | Seminal levels of IL-10, IL-12, and IL-17 in men with asymptomatic chlamydia infection. |
| Q93158322 | Shared and Distinct Functions of Type I and Type III Interferons |
| Q92876039 | Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus |
| Q35661163 | Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine. |
| Q27016078 | Synthetic DNA vaccine strategies against persistent viral infections |
| Q35153129 | Synthetic consensus HIV-1 DNA induces potent cellular immune responses and synthesis of granzyme B, perforin in HIV infected individuals |
| Q92615004 | The IFN-λ Pony Express |
| Q28079550 | The Role of Interferon Lambda 3 Genetic Polymorphisms in Response to Interferon Therapy in Chronic Hepatitis B Patients: An Updated Meta-Analysis |
| Q34575747 | The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation |
| Q36208380 | The impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis C |
| Q40767008 | The improved antibody response against HIV-1 after a vaccination based on intrastructural help is complemented by functional CD8+ T cell responses |
| Q90283971 | The remarkable history of the hepatitis C virus |
| Q90068224 | Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza Vaccines |
| Q34262131 | Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector. |
| Q42411131 | Unique Th1/Th2 Phenotypes Induced during Priming and Memory Phases by Use of Interleukin-12 (IL-12) or IL-28B Vaccine Adjuvants in Rhesus Macaques |
Search more.